Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Net Power A | NPWR | Jul 26, 2024 | 9.61 | +0.95 |
NetApp | NTAP | Jul 26, 2024 | 126.15 | +0.47 |
Netcapital | NCPL | Jul 26, 2024 | 0.09 | -1.89 |
NetEase ADR | NTES | Jul 26, 2024 | 92.59 | -3.00 |
Netflix | NFLX | Jul 26, 2024 | 631.37 | -0.43 |
NETGEAR | NTGR | Jul 26, 2024 | 16.00 | +2.56 |
Netherlands Invstbl Mkt Idx MSCI Ishares | EWN | Jul 26, 2024 | 48.77 | +1.50 |
NetScout Systems | NTCT | Jul 26, 2024 | 20.04 | -1.62 |
NETSOL Technologies | NTWK | Jul 26, 2024 | 2.93 | +1.21 |
Netstreit | NTST | Jul 26, 2024 | 16.86 | +0.84 |
Network-1 Technologies | NTIP | Jul 26, 2024 | 1.61 | +1.90 |
Neuberger Berman | NML | Jul 26, 2024 | 8.02 | +0.50 |
Neuberger Berman High Yield Strategies Fund | NHS | Jul 26, 2024 | 8.00 | +0.31 |
Neuberger Berman Municipal Fund | NBH | Jul 26, 2024 | 11.04 | +0.14 |
Neuberger Berman Next Generation Connectivity Fund | NBXG | Jul 26, 2024 | 12.11 | -0.08 |
Neuberger Berman Real Estate Securities Income Fund | NRO | Jul 26, 2024 | 3.56 | +0.85 |
NeueHealth | NEUE | Jul 26, 2024 | 6.03 | +0.33 |
Neumora Therapeutics | NMRA | Jul 26, 2024 | 12.90 | +3.95 |
Neuraxis | NRXS | Jul 26, 2024 | 3.19 | +2.24 |
Neurobo Pharmaceuticals | NRBO | Jul 26, 2024 | 4.15 | +1.34 |
Neurocrine Biosciences | NBIX | Jul 26, 2024 | 146.80 | +0.48 |
Neurogene | NGNE | Jul 26, 2024 | 44.83 | +4.99 |
NeuroMetrix | NURO | Jul 26, 2024 | 3.70 | -0.16 |
Neuronetics | STIM | Jul 26, 2024 | 1.89 | 0.00 |
NeuroOne | NMTC | Jul 26, 2024 | 0.80 | +0.49 |
Neuropace | NPCE | Jul 26, 2024 | 7.96 | -1.97 |
NeuroSense Therapeutics | NRSN | Jul 26, 2024 | 0.81 | -0.08 |
Nevro | NVRO | Jul 26, 2024 | 9.74 | -1.42 |
New America High Income Fund | HYB | Jul 26, 2024 | 7.44 | +0.40 |
New Concept Energy | GBR | Jul 26, 2024 | 1.50 | -3.66 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.